Drug Trials Snapshots is an FDA initiative that seeks to clearly explain how the clinical studies that led to the approval of a new medication were conducted. Each time a drug is approved for the first time, the FDA publishes a summary for the public showing who participated in the trials, how many people there were, their ages, their sex and their origin, as well as whether the results were similar among those groups.
The purpose is to provide transparency. Basically, to allow anyone to easily review where the information supporting a medication comes from.
How to read a Snapshot
Each Snapshot is made in an easy-to-understand question and answer format. First appears a summary designed for the general public and at the end they include a section with more technical details.
They also show the distribution of participants: how many men, how many women, ages, races and whether there were differences in effects or benefits among these groups.
It is important to remember that a Snapshot does not replace the opinion of a health professional. It is only an informational tool.
What this information is used for
If you or someone close to you is using a new medication, reviewing its Snapshot gives you context.
You can see who participated in the studies, whether people with characteristics similar to yours were included and how they fared. You can also review what side effects were reported and how frequently.
All of this helps a lot to talk with your doctor with greater clarity.
Its limitations
Although they are very useful, Snapshots do not contain everything. They do not include every medication on the market, only those that are completely new at the time of their approval.
Additionally, they do not always show long-term studies. The information may change over time as new data emerges or experience with the medication in the real world expands.
That is why they serve to inform you, but not to make decisions on your own.
Why it's worth knowing them
Because they allow you to see in a more open way how the research behind modern treatments was conducted. For patients, family members and health professionals, these summaries are a very valuable tool for understanding the context of each medication.
Information from: FDA
What's next?
If you want to train your group of KOLs in impact communication and storytelling, we can have an exploratory call to understand your needs and make you a training proposal. Leaderlix trains in impact presentations to the leaders of the most emblematic companies in their industries.